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Introduction
Epileptic seizures represent one of the commonest 
manifestations of acute neurologic disturbances dur-
ing the neonatal period [1]. The concrete seizure 
burden responsible for cerebral damage is still un-
known in literature, having implications in neonatal 
prognostication and treatment. Distinguishing be-
tween etiologic and seizure induced effects on neu-
rodevelopment is challenging and has mostly limit-
ed clinical research on neonatal seizures. 
The aims of this study were to evaluate the vari-
ables associated with adverse neurological outcome 
in term neonates with seizures. 
Subjects and methods
We conducted an observational prospective study 
in a cohort of term newborns (i.e., ≥ 37 weeks ges-
tation), with clinically evident seizures during the 
neonatal period (i.e., within the first 28 days of life), 
who were admitted in the Neonatal Intensive Care 
Unit (NICU) of a single tertiary level hospital, from 
January 2009 to December 2018. Only patients with 
a minimum of two years of neurological follow-up 
were included. Patients who died as consequence of 
the neurologic disorder were included if all required 
data was available and if they had at least one year 
of follow-up. Medical records were reviewed and 
data was collected regarding clinicodemographic 
characteristics, etiology, electroclinical features, 
neuroimaging, antiepileptic treatment and neuro-
logical outcome. 
The diagnosis of neonatal seizures was conclud-
ed by a pediatric neurology consultant based on 
clinical observation or description. Seizures were 
classified according to Volpe’s classification modi-
fied by Lombrose [2], as subtle, focal clonic, multi-
focal clonic, focal tonic, generalized tonic and 
myoclonic phenomena. In patients presenting with 
more than one seizure type, the most representa-
tive manifestation was considered. The time of sei-
zure onset was classified as early if occurring dur-
ing the first 24 hours of life. In all patients, seizure 
investigation required a monitoring video-EEG 
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Introduction. The concrete burden of neonatal seizures in neurodevelopmental outcome of term newborns is still unknown 
in literature. The aim of this study was to describe prognostic predictors in neonatal seizures. 
Subjects and methods. Observational prospective study of term neonates with clinical seizures from a tertiary center 
(2009-2018). Adverse outcome was determined as death, global developmental delay, cerebral palsy or epilepsy. Perinatal 
characteristics, etiology, electrographic features, neuroimaging and antiepileptic treatment were analyzed in a logistic 
regression model. 
Results. A total of 102 newborns were included (52 infants with normal outcome). Twelve fatalities were registered. In the 
survival group, 38 children had an adverse outcome (28 global developmental delay, 27 cerebral palsy, 21 epilepsy). From 
the prognostic variables identified in univariate analysis, perinatal complications, seizure onset in the first day of life, 
moderate to severe abnormal background activity, abnormal amplitude-integrated EEG pattern, and treatment response 
remained independently associated with adverse outcome after a logistic regression model. 
Conclusions. There is conflicting data about surrogate markers in neonatal seizures. Aside from confirming the predictive 
value of previously described variables, we observed that amplitude-integrated EEG monitoring is a forthcoming prognostic 
tool. Future approaches may include a wider use of amplitude-integrated EEG monitoring, being crucial for timely seizure 
identification and prompt treatment. 
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study within 24 hours of the paroxysmal event and 
a minimum record duration of 24 hours. Perinatal 
complications included fetal distress, complicated 
(prolonged/precipitated) labor and resuscitation 
maneuvers. The primary etiology of seizures was 
established by the pediatric neurologist, according 
to clinical history, neuroimaging (cranial ultra-
sonography and brain MRI) and laboratory investi-
gation (including blood and cord pH, when avail-
able). Patients in whom no etiology was deter-
mined through proper investigation were classified 
as unknown. 
EEG recordings were visually analyzed by an ex-
perient pediatric neurophysiologist. Conventional 
EEG (cEEG) was classified with respect to the pres-
ence of interictal/ictal epileptiform discharges and 
abnormal background activity. According to gesta-
tional age, the assessment of background activity 
was based on the voltage depression and asymme-
tries, being further classified as normal/mild or 
moderate/severe abnormality. Whenever available, 
amplitude-integrated EEG (aEEG) was also per-
formed and classification of a normal/abnormal 
pattern was made by a neonatologist or pediatric 
neurologist. The most altered EEG study was used 
for the analysis. Neuroimaging studies (transcranial 
ultrasonography and brain MRI) were considered 
abnormal if there was evidence of cerebral lesions, 
malformations or other remarks. The use of anti-
epileptic drugs as acute or maintenance therapy 
was also assessed.
In our center, clinical surveillance of patients 
with neonatal seizures is made by a pediatric neu-
rologist. The neurological outcome obtained in the 
last follow-up visit was included in the analysis and 
classified as adverse if one or more of the following 
were present: 
– Cerebral palsy, determined according to the ac-
cepted definition as a static, non-progressive and 
permanent condition of movement and motor 
impairment [3]. 
– Global developmental delay, determined accor-
ding to the definition as a significant delay in two 
or more developmental domains [4].
– Epilepsy, determined according to International 
League Against Epilepsy definition guidelines [5]. 
– Death occurring as consequence of the neurolo-
gical sequelae. 
All variables were analyzed in regard to the devel-
opment of a normal or adverse neurological out-
come. Statistical analysis was performed using SPSS 
v. 24 software. Summary statistics were reported as 
mean ± standard deviation. Chi-square test and bi-
nary logistic regressions were used to assess the as-
sociation between dichotomous adverse outcome 
(yes/no) with other variables and combinations. The 
level of significance adopted was α = 0.05. 
Results 
Demographic and clinical data
During the study period, a total of 102 patients 
–56% (n = 57) males and 44% (n = 45) females– 
were included, of whom 51% (n = 52) presented a 
normal outcome. In the adverse outcome group 
(n = 50), 12 case fatalities were registered with a 
mean age of 33 ± 5.8 months (range: 0-72). Thirty-
eight children survived with one or more neurolog-
ical impairment. The most frequent adverse out-
come was global developmental delay (n = 28), fol-
lowed secondly by cerebral palsy (n = 27), from 
which quadriplegic type was the most prevalent 
(n = 9). Seventeen children developed post-natal 
epilepsy plus cerebral palsy and 19 developed post-
natal epilepsy plus global developmental delay. 
Mean follow-up age was 4.7 ± 1.3 years (range: 2-5) 
and mean duration of NICU admission was 8.1 ± 
10.4 days (range: 2-55).
Perinatal features
Mean mother age was 28.9 ± 6.4 years (range: 24-
37). Sixty-nine patients were born from vaginal de-
livery. Mean gestation age was 38.6 ± 2.5 weeks 
(range: 37-41) and mean birth weight was 3211 ± 
535 g (range: 1488-4700). Perinatal complications 
occurred in 38 patients: fetal distress in cardio-
tocography (n = 20), complicated delivery (n = 22), 
and need for resuscitation (n = 9). The mean Apgar 
score at 5th minute was 8.2 ±1 (range: 0-10). In a 
univariate analysis, only the occurrence of perinatal 
complications was significantly associated with an 
adverse neurological outcome (p = 0.04).
Etiology
Hypoxic-ischemic encephalopathy was the most 
common seizure etiology (57%; n = 58), followed by 
perinatal ischemic stroke (16%; n = 16) and intrac-
ranial hemorrhage (12%; n = 12). In a univariate 
analysis, a significant association was observed be-
tween hypoxic-ischemic encephalopathy and ad-
verse outcome (p = 0.03), when compared to other 
etiologies. Case fatalities were also more frequent 
in the former (n = 11).
372 www.neurologia.com Rev Neurol 2019; 69 (9): 370-376
R. Martins, et al
Seizure characteristics
The age of seizure onset ranged from < 24 hours to 
9 days of life. Early seizure onset (i.e., occurring in 
the first day of life) occurred in 39% (n = 40) neo-
nates, of whom 27% (n = 28) patients had an unfa-
vorable outcome. The most common seizure types 
were focal clonic (28%), followed by multifocal 
clonic (19%), generalized tonic (19%) and focal ton-
ic (18%). In a univariate analysis, early seizure onset 
was significantly associated with adverse neurologi-
cal outcome (p = 0.002). No statistical difference 
was observed regarding seizure types, which was 
further confirmed by the analysis of focal clonic 
and non-clonic manifestations (p > 0.20).
EEG 
A total of 82% (n = 83) newborns had an abnormal 
cEEG. Moderate to severe abnormal background 
activity was found in 29% (n = 30) neonates and 
epileptiform activity in 77% (n = 79). In a univariate 
analysis, only moderate to severe abnormal back-
ground was significantly associated with worse 
prognosis (p = 0.001), as no difference was found 
regarding epileptiform activity (p = 0.15). In 91 pa-
tients, aEEG monitoring was performed in addition 
to cEEG and an abnormal pattern was found in 62% 
patients. In univariate analysis, an abnormal aEEG 
pattern was also significantly associated with ad-
verse neurological outcome (p = 0.05).
Neuroimaging
Both neuroimaging studies, brain MRI and trans-
fontanelar ultrasound, were performed in all pa-
tients. In the adverse outcome group, 54% (n = 22) 
and 63% (n = 45) newborns had an abnormal result 
of MRI and transfontanelar ultrasonography, re-
spectively. In a univariate analysis, cranial ultra-
sonography was significantly associated with ad-
verse neurological outcome (p = 0.03) and no dif-
ference was observed regarding brain MRI results 
(p > 0.20).
Treatment
Only two patients did not require antiepileptic 
treatment. During the neonatal period, seizures 
were controlled in 57 newborns with phenobarbital 
on monotherapy. In 43 newborns, one or more an-
tiepileptic drugs were necessary in addition to phe-
nobarbital: midazolam (n = 19), phenytoin (n = 16), 
clonazepam (n = 4), lidocaine (n = 2), and others 
(n = 2). Forty-six patients were discharged on anti-
epileptic treatment. In a univariate analysis, the re-
quirement of add-on antiepileptic drugs to pheno-
barbital was significantly associated with adverse 
outcome (p = 0.002).
Neurological outcome 
From the potential predictors of outcome identified 
in the univariate analysis, the variables perinatal 
complications, early seizure onset, moderate to se-
vere abnormal background activity, abnormal aEEG 
pattern, and administration of add-on antiepileptic 
drugs to phenobarbital remained independently as-
sociated with adverse outcome after a logistic re-
gression model (Table). All patients enrolled in the 
study had available data for these variables. Of note, 
electrographic features of moderate to severe back-
ground abnormality was six times more likely asso-
ciated with unfavorable outcome (odds ratio = 6.25; 
95% confidence interval: 1.89-18.3; p = 0.004) than 
normal or mild background slowing. In addition, in 
our study we equally found that the identification 
of an abnormal aEEG pattern was three times more 
likely to be associated with adverse neurological 
outcome (odds ratio = 2.87; 95% confidence inter-
val: 2.3-14.4; p = 0.03). 
Discussion
Neonatal seizures are the most frequent manifesta-
tion of acute disturbances occurring in the devel-
oping brain [2]. Although the mortality of new-
borns with seizures has significantly declined in the 
last decade due to improved perinatal care [6,7], 
neonatal seizures still pose significant impact on 
long-term morbidity, including neurodevelopmen-
tal disorders [8-10] and epilepsy [9,11-13]. Since 
earlier studies, the most important outcome pre-
dictors have been associated with the underlying 
pathology and severity of brain injury, rather than 
the consequence of seizures per se [6,14,15]. It has 
been generally accepted that subsequent neurologi-
cal impairments are mainly determined by seizure 
etiology, largely represented by hypoxic-ischemic 
encephalopathy or intrapartum asphyxia in full 
term neonates [16]. However, the prognostic value 
for other variables, such as perinatal characteris-
tics, electroclinical features and treatment efficacy 
has not been consensual. Significant variation in 
gestational age, underlying brain insults, as well as 
seizure detection and electrographic analysis, ac-
counts for such discrepant results and has limited 
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an homogenous research on neonatal seizures [17]. 
Despite such restraints, there is converging evi-
dence that seizures independently of etiology [18] 
and certain electrographic patterns represent cru-
cial prognostic markers [19]. 
In this study, we assessed the predictive value of 
a gamut of variables potentially associated with 
outcome. There are major differences between term 
and preterm infants in what concerns etiology, sei-
zure type and morbidity [20,21]. Most previous 
studies have included both term and preterm new-
borns, which may be responsible in some degree 
for the variability observed in prognosis prediction. 
Moreover, several studies concluded that prema-
ture neonates with seizures have higher probability 
of an adverse neurological outcome [9,11,20,22]. 
Evidence on outcome in the particular case of term 
infants with seizures is scant and has been only 
evaluated in two previous studies [8,23]. Therefore, 
we aimed to include a homogenous population of 
exclusively term neonates. Pisani et al scoring sys-
tem [24], which included preterm and term infants, 
identified six independent risk factors for adverse 
neurological outcome: birth weight, Apgar score at 
1 min, neurological examination, cerebral ultra-
sound, efficacy of anticonvulsant therapy, and sta-
tus epilepticus. In order to overcome population 
study differences, Garfinkle et al developed a prog-
nostic scoring system exclusively for term infants 
and identified five independent risk factors: type of 
delivery, seizure onset, seizure type, EEG back-
ground findings, and etiology. Ronen et al have fur-
ther suggested that poor prognostic markers are 
more reliable when combining clinical, electro-
graphic and neuroimaging results than using clini-
cal or EEG criteria alone [9]. 
An increased risk of cerebral palsy, global devel-
opmental delay and post-natal epilepsy has been 
long associated with neonatal seizures. We classi-
fied these disabilities as adverse outcome because 
they often coexist [21]. Our cohort showed a 49% 
prevalence of unfavorable outcome, which is con-
cordant with others observations whose definition 
of adverse prognosis was similar to ours [9,23,25]. 
The burden of epilepsy can be interpreted as a 
marker of brain injury severity, based on the fact 
that infants with epilepsy are equally affected by ce-
rebral palsy and intellectual disability [26]. Never-
theless, this conclusion may be too simplistic, inas-
much as neonatal seizures may also play a synergis-
tic effect in cerebral damage. The rate of post-natal 
epilepsy ranges from 18% to 25% according to hos-
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pital-based series, which is in line with our results. 
However, the incidence in the setting of intensive 
care units may be higher compared to population-
based series, thus reflecting a possible selection bias 
[18,27,28].
As previously reported in other studies, we con-
firmed that hypoxic-ischemic encephalopathy was 
the most frequent etiology [16,29], occurring in 
57% of cases. Albeit associated with worse progno-
sis in the univariate analysis, we did not find statis-
tical significance after a logistic regression model. 
Our findings are in keeping with other case-series 
[23], which suggests that the extent of hypoxic brain 
injury itself accounts for the impaired neurodevel-
opment, rather than the underlying pathology. This 
is further supported by the absence of an associa-
tion found between outcome and MRI or cranial 
ultrasonography abnormal results, as it did not spe-
cifically assess the extension of cerebral injury. Re-
garding variables pertaining to perinatal conditions, 
only perinatal complications (fetal distress, compli-
cated delivery, need for resuscitation) were inde-
pendently associated with adverse outcome. Pre-
term gestational age and low birth weight have been 
extensively reported in relation to prognosis [21,30]. 
In our study, these variables were not related with 
adverse prognosis since we exclusively evaluated 
term newborns. We neither found an association 
with the type of delivery, confirming previous re-
marks that neonatal seizures morbidity is not relat-
ed with cesarean section [22,31].
Seizure type was not associated with adverse 
outcome. A correlation between focal clonic sei-
zures and better prognosis was initially described 
in large case-series [23,32]. However, reproduction 
of such results has not been consistent and further 
studies did not conclude an association between 
semiology and long-term outcome [33,34]. On the 
other hand, we found that seizure onset in the first 
day of life and treatment refractoriness were strong 
predictors. The prognostic value for both variables 
are in keeping with other descriptions [21]. In our 
cohort, we found that neonates requiring additional 
antiepileptic drugs to phenobarbital were seven 
times more likely and neonates with early seizure 
onset were four times more likely to have unfavor-
able prognosis. 
EEG abnormalities in neonatal seizures are well 
documented prognostic markers [35,36]. Interictal 
epileptic activity has been associated with unfavor-
able outcome, in addition to the limited availability 
of ictal recordings. However, numerous studies have 
demonstrated that moderate to severe abnormal 
background is more significantly related with unfa-
vorable prognosis than epileptiform discharges [8, 
23,35]. For this reason, we analyzed cEEG specifi-
cally concerning either the presence of an abnormal 
background or epileptiform activity. Our results 
showed that moderate to severe abnormal back-
ground is an independent predictor of adverse out-
come and we found no difference regarding the 
presence of epileptiform activity. This observation 
corroborates the previous notion that epileptiform 
discharges do not necessarily correlate with the ex-
tension of cerebral injury. 
In addition to cEEG, we assessed the use of aEEG 
as a prognostic tool and observed that an abnormal 
aEEG pattern was also independently associated 
with outcome. In neonatal seizures, evidence about 
the utility of aEEG in predicting prognosis is still 
very scarce in literature. It is generally agreed that 
cEEG has a higher sensibility and specificity in de-
tecting seizures than aEEG [37], therefore our study 
only included newborns in whom aEEG was per-
formed in addition to monitoring video-EEG. One 
previous study authored by Zhang et al also sub-
stantiated an association between abnormal pat-
terns detected on aEEG and long-term adverse out-
come [38]. 
Our study has methodological limitations. Sei-
zures were diagnosed based on clinical description 
by an experient pediatric neurologist, thus reproduc-
ing a real NICU daily setting in which EEG monitor-
ing is not immediately available. This clinical ap-
proach implied a subjective variability in seizure de-
tection. In order to overcome such issue, gold stan-
dard video-EEG monitoring was required to assure a 
higher probability of event recording. In case no 
event was further recorded, the clinical observation 
would still prevail. Another limitation of our study 
was the dichotomic assessment of brain MRI and 
transcranial ultrasonography as normal or abnormal 
results. We speculate that specifically evaluating the 
severity of brain lesions would have been useful, for 
instance in the case of basal ganglia and thalamic le-
sions in hypoxic-ischemic encephalopathy. 
There is a wide range of data in literature about 
surrogate markers of prognosis in neonatal sei-
zures. In our study, the multivariate regression 
analyses denoted that independent variables for ad-
verse neurological outcome were perinatal compli-
cations, early seizure onset, treatment efficacy, mod-
erate to severe background abnormality on cEEG, 
and an abnormal aEEG pattern. In the present 
study, the advantage of using aEEG to evaluate neo-
natal seizures is noteworthy, as abnormal findings 
are readily detectable and have significant prognos-
tic implications. 
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In conclusion, to date neonatal seizures detec-
tion and classification, underlying brain pathology 
and real impact on long-term prognosis are still 
controversial. Aside from confirming the predictive 
value of variables described in previous studies, we 
have observed that aEEG monitoring represents a 
forthcoming prognostic tool. Future approaches 
will be urged by the wider use of long-term aEEG 
monitoring, which is more promptly available in 
the setting of intensive care units than monitoring 
video-EEG. These findings are crucial for timely 
seizure identification and prompt treatment.
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Predictores pronósticos de desarrollo neurológico en recién nacidos a término con crisis neonatales
Introducción. El peso específico de las crisis neonatales en el pronóstico neurológico de recién nacidos a término no se 
conoce bien, por lo que el objetivo del estudio era describir predictores pronósticos en crisis neonatales. 
Sujetos y métodos. Estudio observacional prospectivo de recién nacidos a término con crisis clínicas en un centro terciario 
(2009-2018). Pronóstico adverso se definió como muerte, retraso global del desarrollo, parálisis cerebral o epilepsia. Se 
analizaron las características perinatales, la etiología, los hallazgos electroencefalográficos, la neuroimagen y los trata-
mientos antiepilépticos siguiendo un modelo de regresión logística. 
Resultados. Se incluyó a un total de 102 recién nacidos (52 de los cuales tenían desarrollo normal). Se registraron 12 falle-
cimientos. En el grupo de supervivientes, 38 niños tuvieron un pronóstico desfavorable (28 con retraso global del desarro-
llo, 27 con parálisis cerebral, 21 con epilepsia). De las variables pronósticas identificadas en el análisis univariante, las 
complicaciones perinatales, el inicio de las crisis en el primer día de vida, la actividad basal anormal moderada a grave, un 
patrón anormal en el electroencefalograma de amplitud integrada y la respuesta al tratamiento continuaron mostrándo-
se como independientemente asociadas a pronóstico adverso después de aplicar un modelo de regresión logística. 
Conclusiones. Existen datos contradictorios sobre marcadores subrogados en crisis neonatales. Aparte de confirmar el 
valor predictivo de variables previamente descritas, se halló que la monitorización con electroencefalograma de amplitud 
integrada constituye una prometedora herramienta diagnóstica. En el futuro, se debería extender su utilización en el 
abordaje de estos pacientes, lo que sería de vital importancia para un diagnóstico y un tratamiento precoces.
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